Clinical Trial Update: Clinical Trial for GNX80 in Intermittent Claudication [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for GNX80 in intermittent claudication is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication

Drugs mentioned

• GNX80

Snippet

Sponsor: SK Chemicals Co., Ltd. | Conditions: Intermittent Claudication | Phase 4 | Status: UNKNOWN